Counterfeits penetrate deeper than before, TOPRA hears
This article was originally published in Scrip
Executive Summary
Counterfeit medicinal products are mostly associated with blue pills on the black market, but a TOPRA (The Organisation for Professionals in Regulatory Affairs) conference on the European Commission's legislative proposals for anti-counterfeiting measures was told last Wednesday that criminal gangs now target generic anticancers, branded antipsychotics and sophisticated plasma products.